Publication

Dna polymerase η modulates replication fork progression and dna damage responses in platinum-treated human cells

Sokol, Anna M.
; 
Cruet-Hennequart, Séverine
; 
Pasero, Philippe
; 
Carty, Michael P.
Identifiers
http://hdl.handle.net/10379/13975
 https://doi.org/10.13025/27129
Publication Date
2013-11-20
Keywords
interstrand cross-links, deficient human-cells, xeroderma-pigmentosum, protein-a, s-phase, translesion synthesis, cancer-chemotherapy, structural basis, variant cells, cisplatin-DNA
Type
Article
Downloads
Show all metadata
Citation
Sokol, Anna M. Cruet-Hennequart, Séverine; Pasero, Philippe; Carty, Michael P. (2013). Dna polymerase η modulates replication fork progression and dna damage responses in platinum-treated human cells. Scientific Reports 3 ,
Abstract
Human cells lacking DNA polymerase eta (pol eta) are sensitive to platinum-based cancer chemotherapeutic agents. Using DNA combing to directly investigate the role of pol eta in bypass of platinum-induced DNA lesions in vivo, we demonstrate that nascent DNA strands are up to 39% shorter in human cells lacking pol eta than in cells expressing pol eta. This provides the first direct evidence that pol eta modulates replication fork progression in vivo following cisplatin and carboplatin treatment. Severe replication inhibition in individual platinum-treated pol eta-deficient cells correlates with enhanced phosphorylation of the RPA2 subunit of replication protein A on serines 4 and 8, as determined using EdU labelling and immunofluorescence, consistent with formation of DNA strand breaks at arrested forks in the absence of pol eta. Pol eta-mediated bypass of platinum-induced DNA lesions may therefore represent one mechanism by which cancer cells can tolerate platinum-based chemotherapy.
Funder
Publisher
Springer Nature
Publisher DOI
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland
cbn
Collections
Externally hosted open access publications with University of Galway authors (2)